These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7375788)

  • 21. [Immunocorrective therapy in secondary immunologic deficiency].
    Liashenko IuI
    Voen Med Zh; 1988 Mar; (3):28-30. PubMed ID: 3388785
    [No Abstract]   [Full Text] [Related]  

  • 22. Granulocyte-macrophage colony-stimulating factor as an adjuvant in tumor immunotherapy.
    Fagerberg J
    Med Oncol; 1996 Sep; 13(3):155-60. PubMed ID: 9106174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CpG oligodeoxynucleotides for immune stimulation in cancer immunotherapy.
    Jahrsdörfer B; Weiner GJ
    Curr Opin Investig Drugs; 2003 Jun; 4(6):686-90. PubMed ID: 12901226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunotherapy of sepsis: myth or reality?].
    Vinnitskiĭ LI; Vitvitskaia IM; Popov OIu
    Anesteziol Reanimatol; 1997; (3):89-97. PubMed ID: 9290000
    [No Abstract]   [Full Text] [Related]  

  • 25. [Basic principles of immunocorrective therapy in patients with neurologic manifestations of lumbar osteochondrosis].
    Latysheva VIa; Antonov IP
    Klin Med (Mosk); 1984 Apr; 62(4):116-20. PubMed ID: 6330433
    [No Abstract]   [Full Text] [Related]  

  • 26. Perspectives in immunotherapy.
    Zierhut M; Schlote T; Stübiger N; Stiemer R; Kötter I
    Dev Ophthalmol; 1999; 30():231-44. PubMed ID: 10627927
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunotherapy.
    James DG
    Br J Clin Pract; 1989 Dec; 43(12):433-7. PubMed ID: 2692685
    [No Abstract]   [Full Text] [Related]  

  • 28. [New method in the therapy of cancer. Interview granted to Minerva Medica by Prof. Augusto Pederzini].
    Carafa M
    Minerva Med; 1973 Apr; 64(25):3-6. PubMed ID: 4709744
    [No Abstract]   [Full Text] [Related]  

  • 29. Managing HIV. Part 4: Primary therapy. 4.2 Immune-based therapy for HIV infection.
    Benson EM; French MA; Schooley RT
    Med J Aust; 1996 Mar; 164(5):297-300. PubMed ID: 8628166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prospects of immunotropic therapy of traumatic uveitis].
    Valeeva RG; Grishina VS; Iluridze SL; Isaeva RT
    Vestn Oftalmol; 1998; 114(4):26-8. PubMed ID: 9771084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant immunotherapy in colorectal cancer.
    Vermorken JB
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):66-71. PubMed ID: 11049049
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immunotherapy in non-allergic diseases].
    Español T
    Allergol Immunopathol (Madr); 2000; 28(3):107-9. PubMed ID: 10867379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modern techniques of immunomodulation in rheumatoid arthritis.
    Codreanu C
    Roum Arch Microbiol Immunol; 1993; 52(3):149-56. PubMed ID: 7833528
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immunomodulatory/suppressive treatments in neurology].
    Schluep M; Chofflon M; Kuntzer T; Du Pasquier R
    Rev Med Suisse; 2005 May; 1(18):1229-32. PubMed ID: 15977712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunotherapy].
    Xie SW
    Zhonghua Nei Ke Za Zhi; 1984 Mar; 23(3):176-8. PubMed ID: 6207997
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunosuppressive agents, gamma-globulin, immunomodulation, immunization, and apheresis.
    Kniker WT
    J Allergy Clin Immunol; 1989 Dec; 84(6 Pt 2):1104-7. PubMed ID: 2480974
    [No Abstract]   [Full Text] [Related]  

  • 37. Topical immunotherapy: what's new.
    Sauder DN; Mofid MZ
    Dermatol Clin; 2005 Apr; 23(2):245-58. PubMed ID: 15837154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disease-modifying drugs for the early treatment of multiple sclerosis.
    Flachenecker P
    Expert Rev Neurother; 2004 May; 4(3):455-63. PubMed ID: 15853542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunosuppression and immunopotentiation in the treatment of skin diseases].
    Wereide K
    Tidsskr Nor Laegeforen; 1983 Apr; 103(10):841-4. PubMed ID: 6879520
    [No Abstract]   [Full Text] [Related]  

  • 40. [New therapies in the management of seropositive persons].
    Riou JM
    Soins; 2009 Apr; (734):54. PubMed ID: 19475834
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.